Take advantage of continuously-streaming biosensor data and FDA-cleared analytics to generate unprecedented patient in-sight.
Tap into the power of continuous, real-world, real-time analytics:
Help identify post-acute patients whose health may be worsening, potentially enabling clinicians to administer proactive care before their condition requires hospitalization.
Let our algorithms do the heavy lifting of analyzing clinical-grade continuous vital signs, thereby offering your clinical staff a powerful tool to inform those who may be at risk for acute deterioration.
Leverage disease-agnostic analytical versatility capable of indicating personalized changes, which may be precursors of deteriorating health not limited to any particular condition or comorbidity.
Increase your speed to market by proving safety and efficacy while achieving participant satisfaction, compliance, and more:
Tap into a rich and robust physiological data set providing a new level of real-world insight for evaluating and quantifying therapeutic safety and efficacy relative to a personalized baseline, in a way that also enables statistical cross-cohort analysis.
Leverage novel biomarkers from continuous real-world physiological data sets connected to the cloud, which allow you to more quickly identify and address adverse reactions.
At physIQ, we welcome the opportunity to speak with potential customers, partners, or anyone with an interest in learning more about the transformative potential of our technology.Contact Us